Aviva PLC Harmony Biosciences Holdings, Inc. Transaction History
Aviva PLC
- $39.7 Billion
- Q1 2025
A detailed history of Aviva PLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Aviva PLC holds 17,880 shares of HRMY stock, worth $602,913. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,880
Previous 18,072
1.06%
Holding current value
$602,913
Previous $621,000
4.51%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$223 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$197 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$158 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$53.2 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$43.5 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.99B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...